During endoscopic procedures for suspected urothelial tumors of the upper urinary tract, radiographic imaging using an iodinated contrast medium is often required. However, following ureteropyelography, we detected changes in cytology characteristics not correlating with real cytology findings in naive urine. The aim of our study was to assess cytology changes between naive and postcontrast urine according to The Paris System of cytology classification. Methods: We prospectively assessed urine samples from 89 patients (23 patients with histologically proven urothelial cancer and 66 healthy volunteers). The absence of malignancy was demonstrated by CT urography and/or ureteroscopy. The study was single blind (expert cytopathologist) and naïve Paris system for urine cytology assessment was used. Furthermore, additional cytological parameters were analyzed (e.g., specimen cellularity, degree of cytolysis, cytoplasm and nucleus color, chromatin and nucleo-cytoplasmic ratio). Results: Our study showed statistically significant differences when comparing naïve and postcontrast urine in healthy volunteers (only 51 % concordance, p = 0.001) versus malignant urine specimens (82 % concordance). The most important differences were in the shift from The Paris System category 2 (negative) to 1 (non-diagnostic) and from category 2 (negative) to 3 (atypia). Other significant changes were found in the assessment of specimen cellularity (p = 0.0003), degree of cytolysis (p = 0.001), cytoplasm color (p = 0.003), hyperchromasia (p = 0.001), course chromatin (p = 0.002), nucleo-cytoplasmatic ratio (p = 0.001) and nuclear borders' irregularity (p = 0.01). Conclusion: Our unique study found crucial changes in the cytological assessment of naive and postcontrast urine and we confirm that postcontrast urine is more often assessed as abnormal, suspect or non-diagnostic. Therefore, before urine collection for cytology, the clinician should avoid administration of iodinated contrast into the urinary tract.

Department of Clinical and Molecular Pathology Institute of Molecular and Translational Medicine Medical Faculty Palacký University 77900 Olomouc Czech Republic

Department of Clinical and Molecular Pathology University Hospital Olomouc 77900 Olomouc Czech Republic

Department of Medical Biophysics Medical Faculty Palacký University 77900 Olomouc Czech Republic

Department of Urology University Hospital Olomouc 77900 Olomouc Czech Republic

See more in PubMed

EAU Guidelines; Edn. Presented at the EAU Annual Congress Milan 2021. ISBN 978-94-92671-13-4. [(accessed on 3 February 2022)]. Available online: https://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/#11.

Barkan G.A., Wojcik E.M., Nayar R., Savic-Prince S., Quek M.L., Kurtycz D.F.I., Rosenthal D.L. The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology. Acta Cytol. 2016;60:185–197. doi: 10.1159/000446270. PubMed DOI

Rosenthal D.L., Wojcik E.M., Kurtycz D. The Paris System for Reporting Urinary Cytology. 2nd ed. Springer; Cham, Switzerland: 2022. PubMed

Okuda C., Kyotake A., Nakamura A., Itoh T., Kamoshida S., Ohsaki H. Quantitative Cytomorphological Comparison of SurePath and ThinPrep Liquid-Based Cytology Using High-Grade Urothelial Carcinoma Cells. Cytopathology. 2021;32:654–659. doi: 10.1111/cyt.12998. PubMed DOI

Gupta M., Milbar N., Tema G., Pederzoli F., Chappidi M., Kates M., VandenBussche C.J., Bivalacqua T.J. Impact of Intravesical Therapy for Non-Muscle Invasive Bladder Cancer on the Accuracy of Urine Cytology. World J. Urol. 2019;37:2051–2058. doi: 10.1007/s00345-018-02624-3. PubMed DOI

Kassouf W. The Value of Urine Cytology in the Workup of Hematuria. Cancer Cytopathol. 2016;124:303–304. doi: 10.1002/cncy.21700. PubMed DOI

Papanicolaou G.N. Cytology of the Urine Sediment in Neoplasms of the Urinary Tract. J. Urol. 1947;57:375–379. doi: 10.1016/S0022-5347(17)69643-5. PubMed DOI

Layfield L.J., Elsheikh T.M., Fili A., Nayar R., Shidham V. Review of the State of the Art and Recommendations of the Papanicolaou Society of Cytopathology for Urinary Cytology Procedures and Reporting: The Papanicolaou Society of Cytopathology Practice Guidelines Task Force. Diagn. Cytopathol. 2004;30:24–30. doi: 10.1002/dc.10401. PubMed DOI

Barcia J.J. The Giemsa Stain: Its History and Applications. Int. J. Surg. Pathol. 2007;15:292–296. doi: 10.1177/1066896907302239. PubMed DOI

Muus Ubago J., Mehta V., Wojcik E.M., Barkan G.A. Evaluation of Atypical Urine Cytology Progression to Malignancy. Cancer Cytopathol. 2013;121:387–391. doi: 10.1002/cncy.21278. PubMed DOI

Long T., Layfield L.J., Esebua M., Frazier S.R., Giorgadze D.T., Schmidt R.L. Interobserver Reproducibility of The Paris System for Reporting Urinary Cytology. Cytojournal. 2017;14:17. doi: 10.4103/cytojournal.cytojournal_12_17. PubMed DOI PMC

Bakkar R., Mirocha J., Fan X., Frishberg D.P., de Peralta-Venturina M., Zhai J., Bose S. Impact of the Paris System for Reporting Urine Cytopathology on Predictive Values of the Equivocal Diagnostic Categories and Interobserver Agreement. Cytojournal. 2019;16:21. doi: 10.4103/cytojournal.cytojournal_30_19. PubMed DOI PMC

Renshaw A.A., Nappi D., Weinberg D.S. Cytology of Grade 1 Papillary Transitional Cell Carcinoma. A Comparison of Cytologic, Architectural and Morphometric Criteria in Cystoscopically Obtained Urine. Acta Cytol. 1996;40:676–682. doi: 10.1159/000333938. PubMed DOI

VandenBussche C.J., Rosenthal D.L., Olson M.T. Adequacy in Voided Urine Cytology Specimens: The Role of Volume and a Repeat Void upon Predictive Values for High-Grade Urothelial Carcinoma. Cancer Cytopathol. 2016;124:174–180. doi: 10.1002/cncy.21634. PubMed DOI

Wojcik E.M. What Should Not Be Reported as Atypia in Urine Cytology. J. Am. Soc. Cytopathol. 2015;4:30–36. doi: 10.1016/j.jasc.2014.08.001. PubMed DOI

Reid M.D., Osunkoya A.O., Siddiqui M.T., Looney S.W. Accuracy of Grading of Urothelial Carcinoma on Urine Cytology: An Analysis of Interobserver and Intraobserver Agreement. Int. J. Clin. Exp. Pathol. 2012;5:882–891. PubMed PMC

Kurtycz D.F.I., Barkan G.A., Pavelec D.M., Rosenthal D.L., Wojcik E.M., VandenBussche C.J., Mangiulli K., Olson M.T. Paris Interobserver Reproducibility Study (PIRST) J. Am. Soc. Cytopathol. 2018;7:174–184. doi: 10.1016/j.jasc.2018.02.005. PubMed DOI

Rosenthal D.L., Vandenbussche C.J., Burroughs F.H., Sathiyamoorthy S., Guan H., Owens C. The Johns Hopkins Hospital Template for Urologic Cytology Samples: Part I-Creating the Template. Cancer Cytopathol. 2013;121:15–20. doi: 10.1002/cncy.21255. PubMed DOI

VandenBussche C.J., Sathiyamoorthy S., Owens C.L., Burroughs F.H., Rosenthal D.L., Guan H. The Johns Hopkins Hospital Template for Urologic Cytology Samples: Parts II and III: Improving the Predictability of Indeterminate Results in Urinary Cytologic Samples: An Outcomes and Cytomorphologic Study. Cancer Cytopathol. 2013;121:21–28. doi: 10.1002/cncy.21254. PubMed DOI

Brimo F., Auger M. The Atypical Urothelial Cell Category in the Paris System: Strengthening the Achilles’ Heel. Cancer Cytopathol. 2016;124:305–306. doi: 10.1002/cncy.21668. PubMed DOI